Pharma companies team up with DeSci to accelerate scientific research
Pfizer is now the first big pharma to participate in a decentralized autonomous organization (DAO). Having emerged as a movement in the research community, Decentralized Science (DeSci) initiatives are progressing at a pace even big pharma cannot ignore. In fact, Pfizer is now the first pharmaceutical to vote on decentralized autonomous organization (DAO) proposals of German blockchain-based organization VitaDAO. The collaboration is part of VitaDAO's latest fundraising disclosed in late January from strategic members, including Pfizer Ventures, Shine Capital and L1 Digital, among other longevity enthusiasts. The $4.1 million raised will be used to fund longevity research projects and accelerate the spinout of VitaDAO's first biotech startups, with two more in development for 2023. "Pfizer is now bringing some of their own scientists to join with the community of research ers who are part of Vita DAO to help incubate some of this research ," told Cointelegraph A...